Link to this page
COVID-19 Ontology
Last uploaded:
February 25, 2021
Jump to:
Preferred Name | tocilizumab | |
Synonyms |
|
|
ID |
http://purl.obolibrary.org/obo/DRON_00019607 |
|
fromPubMed |
true
|
|
has_RxCUI |
612865
|
|
imported from | ||
label |
tocilizumab
|
|
oboInOwl:hasDbXRef | ||
oboInOwl:hasDefinition |
A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. Il-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.
|
|
preferred label |
tocilizumab
|
|
prefixIRI |
DRON:00019607
|
|
prefLabel |
tocilizumab
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping